Skip to main content
Log in

Asenapine cost effective versus olanzapine in bipolar I disorder

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. funded by Lundbeck Italy, SpA

Reference

  • Caresano C, et al. Cost-Effectiveness of Asenapine in the Treatment of Patients with Bipolar I Disorder with Mixed Episodes in an Italian Context. Advances in Therapy : 24 Jul 2014

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asenapine cost effective versus olanzapine in bipolar I disorder. PharmacoEcon Outcomes News 709, 3 (2014). https://doi.org/10.1007/s40274-014-1444-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1444-4

Navigation